Small intestinal metastasis of triple-negative breast cancer mimicking lymphoma: imaging findings and case report - Report - MDSpire

Small intestinal metastasis of triple-negative breast cancer mimicking lymphoma: imaging findings and case report

  • By

  • Lin-Ying Ma

  • Xiao-Shan Huang

  • Shu-Feng Fan

  • Li-Ming Xue

  • July 9, 2026

  • 0 min

Share

Clinical Report: Metastasis of Triple-Negative Breast Cancer to the Small Intestine

Background

Small intestinal metastasis from breast cancer is uncommon and often presents with non-specific symptoms, which can lead to diagnostic delays. Understanding the imaging characteristics and clinical presentations is crucial for timely diagnosis and management.

Data Highlights

No numerical data provided in the source material.

Key Findings

  • The patient presented with unexplained anemia and positive fecal occult blood tests.
  • Imaging revealed segmental, asymmetric wall thickening of the small bowel, raising suspicion for lymphoma.
  • Endoscopy showed a large circumferential deep ulcerative lesion, indistinguishable from primary small bowel adenocarcinoma or lymphoma.
  • Histopathological evaluation confirmed small intestinal metastasis from triple-negative breast cancer.
  • Clinicians should consider small bowel metastasis in breast cancer survivors with unexplained gastrointestinal symptoms.

Clinical Implications

Clinicians should be vigilant for atypical presentations of metastasis in breast cancer survivors, particularly unexplained anemia and gastrointestinal symptoms.

Conclusion

This case highlights the need for awareness of atypical manifestations of metastatic breast cancer.

Related Resources & Content

  1. Author(s)/Org, Source, Year -- Title
  2. Author(s)/Org, Source, Year -- Title
  3. Author(s)/Org, Source, Year -- Title
  4. Author(s)/Org, Source, Year -- Title
  5. Author(s)/Org, Source, Year -- Title
  6. Author(s)/Org, Source, Year -- Title
  7. Infection — Tuberculosis of the Peritoneum
  8. Gastrointestinal spread from breast cancer: a literature review
  9. Radiologic Review of Small Bowel Malignancies
  10. https://www.thieme-connect.com/products/ejournals/html/10.1055/a-1973-3796?utm_source=openai
  11. Immunohistochemical Markers for Distinguishing Metastatic Breast Carcinoma from Other Common Malignancies: Update and Revisit - ScienceDirect
  12. Biomarkers for Systemic Therapy in Metastatic Breast Cancer: ASCO Guideline Update | Journal of Clinical Oncology
  13. Updated treatment recommendations for systemic treatment: from the ESMO Metastatic Breast Cancer Living Guideline
  14. Pembrolizumab plus Chemotherapy in Advanced Triple-Negative Breast Cancer | New England Journal of Medicine
  15. Sacituzumab Govitecan in Metastatic Triple-Negative Breast Cancer | New England Journal of Medicine
  16. Trastuzumab deruxtecan (T-DXd) versus treatment of physician’s choice (TPC) in patients (pts) with HER2-low unresectable and/or metastatic breast cancer (mBC): Results of DESTINY-Breast04, a randomized, phase 3 study. | Journal of Clinical Oncology
  17. Sacituzumab Govitecan plus Pembrolizumab for Advanced Triple-Negative Breast Cancer - PubMed
  18. 5th ESO-ESMO international consensus guidelines for advanced breast cancer (ABC 5) - PMC

Original Source(s)

Related Content